热线电话: 021-34661275
产品分类/PRODUCT CLASSIFICATION

上海细胞库

人源细胞系| 稳转细胞系| 基因敲除株| 基因点突变细胞株| 基因过表达细胞株| 重组细胞系| 猪的细胞系| 马细胞系| 兔的细胞系| 犬的细胞系| 山羊的细胞系| 鱼的细胞系| 猴的细胞系| 仓鼠的细胞系| 狗的细胞系| 牛的细胞| 大鼠细胞系| 小鼠细胞系| 其他细胞系|

原代细胞

原代细胞| 永生化细胞|

细胞培养

血清| 无血清冻存| 细胞培养试剂盒| 普通培养基| 完全培养基| 细胞污染预防| 细胞污染清除| 细胞培养辅助试剂|

细胞服务

STR鉴定服务| ATCC代购服务|

酶联试剂盒

人ELISA试剂盒| 大鼠ELISA试剂盒| 小鼠ELISA试剂盒| 兔ELISA试剂盒| 猪ELISA试剂盒| 鱼ELISA试剂盒| 牛ELISA试剂盒| 犬ELISA试剂盒| 鸭ELISA试剂盒| 豚鼠ELISA试剂盒| 鸡ELISA试剂盒| 绵羊ELISA试剂盒| 山羊ELISA试剂盒| 仓鼠ELISA试剂盒| 植物ELISA试剂盒| 药残留类试剂盒| 其他ELISA试剂盒|

生化试剂盒

生化试剂盒| 微量法检测盒| 分光法检测盒| 胶体金检测盒|

PCR试剂盒

荧光探针PCR试剂盒| 染料荧光PCR试剂盒| 核酸扩增/纯化| 普通PCR检测试剂盒| 质粒菌种感受态|

抗体蛋白

蛋白多肽| 抗体| 免疫组化| 免疫球蛋白|

试剂耗材

标准试液| 科研试剂| 缓 冲 液| 实验耗材| 高效液相色谱对照品|

首页 > 抗体蛋白 > 抗体
PerCP/Cyanine5.5 anti-mouse CD4 Antibody
产品名称：
PerCP/Cyanine5.5 anti-mouse CD4 Antibody
产品类别：
抗体
产品编号：
100539
产品应用：
100539
[价格]
规格 价格 库存
25µg ￥ 1442 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
BALB/c mouse thymocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PerCP/Cyanine5.5 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD4 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is = 0.25 ?g per 106 cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.

* PerCP/Cyanine5.5 has a maximum absorption of 482 nm and a maximum emission of 690 nm.

Application Notes

The RM4-5 antibody blocks the binding of GK1.5 antibody and H129.19 antibody to CD4+ T cells, but not RM4-4 antibody. Additional reported applications (for the relevant formats) include: blocking of ligand binding, in vivo depletion of CD4+ cells1, and immunohistochemistry of acetone-fixed frozen tissue sections2,3,11 and paraffin-embedded sections11. Clone RM4-5 is not recommended for immunohistochemistry of formalin-fixed paraffin sections. Instead, acetone frozen or zinc-fixed paraffin sections are recommended. The Ultra-LEAF? Purified antibody (Endotoxin < 0.01 EU/?g, Azide-Free, 0.2 ?m filtered) is recommended for functional assays (Cat. No. 100575 and 100576).

Additional Product Notes

BioLegend is in the process of converting the name PerCP/Cy5.5 to PerCP/Cyanine5.5. The dye molecule remains the same, so you should expect the same quality and performance from our PerCP/Cyanine5.5 products. Contact Technical Service if you have any questions.

Application References

(PubMed link indicates BioLegend citation)
  1. Kruisbeek AM. 1991. In Curr. Protocols Immunol. pp. 4.1.1-4.1.5. (Block, Deplete)
  2. Nitta H, et al. 1997. Cell Vision 4:73. (IHC)
  3. Fan WY, et al. 2001. Exp. Biol. Med. 226:1045.
  4. Muraille E, et al. 2003. Infect. Immun. 71:2704. (IHC)
  5. León-Ponte M, et al. 2007. Blood 109:3139. (FC)
  6. Bourdeau A, et al. 2007. Blood doi:10.1182/blood-2006-08-044370. (FC)
  7. Matsumoto M, et al. 2007.J. Immunol.178:2499. PubMed
  8. Shigeta A, et al. 2008. Blood 112:4915. PubMed
  9. Zaborsky N, et al. 2010. J. Immunol. 184:725. PubMed
  10. Rodrigues-Manzanet R, et al. 2010. P. Natl Acad Sci USA 107:8706. PubMed
  11. Whiteland JL, et al. 1995. J. Histochem. Cytochem. 43:313. (IHC)
Product Citations
  1. Zheng J, et al. 2022. Front Pharmacol. 13:866228. PubMed
  2. Lee SA, et al. 2020. J Immunol. 204:586. PubMed
  3. Delvecchio FR, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1543. PubMed
  4. Li JY, et al. 2020. J Clin Invest. 130:1767. PubMed
  5. Kim TJ, et al. 2019. Nat Commun. 10:3258. PubMed
  6. Baldwin SL, et al. 2021. PLoS One. 16:e0247990. PubMed
  7. Hewitson JP, et al. 2020. J Immunol. 204:2949. PubMed
  8. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  9. Schmidleithner L et al. 2019. Immunity. 50(5):1232-1248 . PubMed
  10. Tyagi AM et al. 2018. Immunity. 49(6):1116-1131 . PubMed
  11. B?ttcher JP, et al. 2018. Cell. 172:1022. PubMed
  12. Castiglioni A, et al. 2015. PLoS One. 10:128094. PubMed
  13. Isakova-Sivak I, et al. 2020. Vaccines (Basel). 8:00. PubMed
  14. Hayatsu N et al. 2017. Immunity. 47(2):268-283 . PubMed
  15. Zhang F, et al. 2019. Nat Commun. 10:3974. PubMed
  16. Kitano M, et al. 2016. Proc Natl Acad Sci U S A. 113: 1044 - 1049. PubMed
  17. Sharma S, et al. 2015. J Immunol. 194:5529. PubMed
  18. Yu M, et al. 2021. J Clin Invest. 131:. PubMed
  19. Solanki A, et al. 2018. Development. 145. PubMed
  20. Willingham SB, et al. 2018. Cancer Immunol Res. 6:1136. PubMed
  21. Voisin M, et al. 2021. Commun Biol. 4:420. PubMed
  22. Tuganbaev T, et al. 2020. Cell. 182(6):1441-1459.e21. PubMed
  23. JI B, et al. 2016. Cell Death Differ. 23:759-75. PubMed
  24. Burrack K, et al. 2015. PLoS Pathog. 11: e1005191. PubMed
  25. Leonard JD et al. 2017. Immunity. 47(1):107-117 . PubMed
  26. Luo Y et al. 2019. Cell reports. 26(7):1869-1879 . PubMed
  27. Miska J et al. 2019. Cell reports. 27(1):226-237 . PubMed
  28. Drees J, et al. 2015. Anticancer Res. 35:843. PubMed
  29. Tyagi AM, et al. 2021. eLife. 10:00. PubMed
  30. Yue X, et al. 2019. Nat Commun. 10:2011. PubMed
  31. Alikhanyan K, et al. 2021. Cancers (Basel). 13:. PubMed
  32. Gniadek TJ, et al. 2020. J Immunother. 43:217. PubMed
  33. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  34. Vogel AB, et al. 2021. Nature. 592:283. PubMed
  35. White C, et al. 2015. J Immunol. 194:697. PubMed
  36. Alikhanyan K, et al. 2020. Immun Inflamm Dis. 8:181. PubMed
  37. Alameh MG, et al. 2021. Immunity. 54:2877. PubMed
  38. Bosnjak B, et al. 2021. Front Immunol. 12:772240. PubMed
  39. Shen JZ, et al. 2020. Cell. 184(2):352-369.e23. PubMed
  40. Li X, et al. 2020. Nat Commun. 4.877777778. PubMed
  41. Ishikawa E, et al. 2016. Nat Commun. 7: 12756. PubMed
  42. Lim S, et al. 2016. PLoS One. 11: 0155689. PubMed
  43. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  44. Duan H et al. 2018. Immunity. 49(2):301-311 . PubMed
  45. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  46. Shiozawa S, et al. 2022. iScience. 25:103537. PubMed
  47. Lebrun A, et al. 2015. J Immunol. 195: 4358 - 4368. PubMed
  48. Muri J, et al. 2020. eLife. 9:e53627.. PubMed
  49. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
  50. Yasuma K, et al. 2016. PLoS Pathog. 12: 1005372. PubMed
  51. Chen X, et al. 2021. Immunity. 54(2):324-339.e8. PubMed
  52. Chen X, et al. 2019. Med Sci Monit. 25:5389. PubMed
  53. Nagashima H et al. 2019. Immunity. 51(4):682-695 . PubMed
  54. Yue X, et al. 2021. EMBO Rep. 22:e52716. PubMed
  55. Lainé A, et al. 2021. Nat Commun. 12:6228. PubMed
  56. Sun X, et al. 2017. Microbes Infect. 10.1016/j.micinf.2017.08.007. PubMed
  57. Shaikh H, et al. 2021. Front Immunol. 12:689896. PubMed
  58. Hoechst B, et al. 2016. J Immunol. 195:1517-1523. PubMed
  59. Matsumoto M, et al. 2021. Cell Host Microbe. 29(6):930-940.e4. PubMed
  60. Ren S, et al. 2022. Int J Biol Sci. 18:166. PubMed
  61. Lederer K, et al. 2020. Immunity. 53(6):1281-1295.e5. PubMed
  62. Rossnagl S, et al. 2016. PLoS Biol. 14: 1002562. PubMed
  63. Zeng J, et al. 2020. Int J Biol Sci. 1.939583333. PubMed
  64. Aalipour A, et al. 2020. Mol Ther Oncolytics. 17:232. PubMed
  65. Kunishita Y, et al. 2020. Front Immunol. 11:98. PubMed
  66. Silva HM, et al. 2019. J Exp Med. 216:786. PubMed
  67. Chen X, et al. 2022. STAR Protoc. 3:101180. PubMed
  68. Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed
  69. Tan DQ, et al. 2019. Cell Rep. 26:2316. PubMed
  70. Yang F, et al. 2021. Nat Commun. 12:3424. PubMed
RRID
AB_893332 (BioLegend Cat. No. 100539) AB_893326 (BioLegend Cat. No. 100540)

Antigen Details

Structure
Ig superfamily, 55 kD
Distribution

Majority of thymocytes, T cell subset

Function
TCR co-receptor, T cell activation
Ligand/Receptor
MHC class II molecule
Cell Type
Dendritic cells, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Bierer BE, et al. 1989. Annu. Rev. Immunol. 7:579.
3. Janeway CA. 1992. Annu. Rev. Immunol. 10:645.

Gene ID
12504 View all products for this Gene ID
UniProt
View information about CD4 on UniProt.org

联系我们

TEL：021-34661275 　点击拨打热线